amobarbital has been researched along with Developmental Psychomotor Disorders in 2 studies
Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schulze-Bonhage, A | 1 |
| Saario, I | 1 |
| Linnoila, M | 1 |
1 trial available for amobarbital and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Effect of subacute treatment with hypnotics, alone or in combination with alcohol, on psychomotor skills related to driving.
Topics: Adult; Alcoholic Intoxication; Amobarbital; Attention; Automobile Driving; Clinical Trials as Topic; | 1976 |
1 other study available for amobarbital and Developmental Psychomotor Disorders
| Article | Year |
|---|---|
Selective middle cerebral artery Wada tests for evaluation of motor representation.
Topics: Amobarbital; Dominance, Cerebral; Epilepsy; Hemispherectomy; Humans; Middle Cerebral Artery; Patient | 2003 |